For the third time in the past four weeks, stocks within the medtech industry climbed to never-before-seen heights as 2021 reared its head. Previous highs have largely been a result of the FDA granting Moderna emergency use authorization for its vaccine candidate and its subsequent rollout to the U.S., joining the one made by Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX), […]
Corinth MedTech
Corinth MedTech receives $5M venture loan
Horizon Technology Finance Corporation announced yesterday that it provided a $5 million venture loan to Corinth MedTech. San Jose, Calif.-based Corinth develops the FDA-cleared Veloxion system for treating symptoms related to benign prostatic hyperplasia (BPH), also known as TURP for enlarged prostate, according to a news release. Veloxion includes a resectoscope with an integrated camera, […]
Biomet vet Serbousek to succeed Mason as Orthofix CEO | Personnel Moves, August 13, 2019
Orthofix (NSDQ:OFIX) last week named a successor for president & CEO Brad Mason in November, tapping Jon Serbousek as president of its spine business effective August 5. Mason is slated to retire Oct. 31; Serbousek, a 30-year medtech veteran with stints at Biomet, Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) unit DePuy Orthopaedics, is due to […]
Corinth MedTech raises $12m for Veloxion urology device
Corinth MedTech said last week that it raised a $12 million Series D round for the urology device it’s developing. Cupertino, Calif.-based Micro Medical’s Veloxion device is designed to treat benign prostate hyperplasia and bladder tumors under continuous flow conditions using a bipolar resecting device, a fluid management system and integrated visualization technology. Proceeds from […]
